WaveMan · Form 4
Narayen Shantanu insider trades
> Search tickers & screens ⌘K
LIVE

Narayen Shantanu insider trades

Narayen Shantanu has filed 68 Form 4s with the SEC that we hold, for Adobe INC. (ADBE) (Chair and CEO, Director) and Pfizer INC (PFE) (Director). Across all of them we count 0 purchases worth $0 and 47 sales worth $142.1M reported on Form 4. In the last 12 months: 0 purchases ($0) and 15 sales ($49.6M). The largest single trade was a sale of 51,422 shares of Adobe INC. worth $12.5M, dated 2026-04-28. Of 12 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-06 and the latest 2026-09-29.

Adobe INC. (ADBE)

Chair and CEO, Director · 41 filings · 47 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-24S, sale reported on Form 42,487$1.5M2021-09-27
2021-09-24S, sale reported on Form 47,838$4.9M2021-09-27
2021-09-24S, sale reported on Form 46,838$4.2M2021-09-27
2021-09-24S, sale reported on Form 410,152$6.3M2021-09-27
2021-09-24S, sale reported on Form 412,685$7.8M2021-09-27
2023-01-20S, sale reported on Form 41,548$536.6K2023-01-23
2023-01-20S, sale reported on Form 44,064$1.4M2023-01-23
2023-01-20S, sale reported on Form 42,040$711.3K2023-01-23
2023-01-20S, sale reported on Form 41,491$520.9K2023-01-23
2023-01-20S, sale reported on Form 42,755$946.6K2023-01-23
2023-01-20S, sale reported on Form 41,932$667.3K2023-01-23
2023-01-20S, sale reported on Form 41,170$403.2K2023-01-23
2023-06-22S, sale reported on Form 41,909$917.4K2023-06-22
2023-06-22S, sale reported on Form 45,462$2.6M2023-06-22
2023-06-22S, sale reported on Form 413,624$6.5M2023-06-22
2023-06-22S, sale reported on Form 44,832$2.3M2023-06-22
2023-06-22S, sale reported on Form 46,026$2.9M2023-06-22
2023-06-22S, sale reported on Form 43,147$1.5M2023-06-22
2023-12-22S, sale reported on Form 44,155$2.5M2023-12-26
2023-12-22S, sale reported on Form 48,335$5.0M2023-12-26
2023-12-22S, sale reported on Form 410,293$6.2M2023-12-26
2023-12-22S, sale reported on Form 49,217$5.5M2023-12-26
2024-06-27S, sale reported on Form 42,612$1.4M2024-06-28
2024-06-27S, sale reported on Form 46,154$3.3M2024-06-28
2024-06-27S, sale reported on Form 413,871$7.5M2024-06-28
2024-06-27S, sale reported on Form 42,363$1.3M2024-06-28
2024-09-25S, sale reported on Form 412,055$6.3M2024-09-26
2024-09-25S, sale reported on Form 44,009$2.1M2024-09-26
2024-09-25S, sale reported on Form 44,199$2.2M2024-09-26
2024-09-25S, sale reported on Form 42,635$1.4M2024-09-26
2024-09-25S, sale reported on Form 41,752$919.6K2024-09-26
2024-09-25S, sale reported on Form 4350$184.0K2024-09-26
2026-04-28S, sale reported on Form 451,422$12.5M2026-04-30
2026-04-28S, sale reported on Form 410,341$2.5M2026-04-30
2026-04-28S, sale reported on Form 413,237$3.2M2026-04-30
2026-09-16S, sale reported on Form 48,358$2.1M2026-09-18
2026-09-16S, sale reported on Form 433,001$8.3M2026-09-18
2026-09-16S, sale reported on Form 420,716$5.2M2026-09-18
2026-09-16S, sale reported on Form 411,495$2.9M2026-09-18
2026-09-16S, sale reported on Form 4930$235.9K2026-09-18
2026-09-17S, sale reported on Form 41,378$339.1K2026-09-18
2026-09-17S, sale reported on Form 43,430$848.4K2026-09-18
2026-09-17S, sale reported on Form 47,168$1.8M2026-09-18
2026-09-17S, sale reported on Form 410,313$2.6M2026-09-18
2026-09-17S, sale reported on Form 417,595$4.4M2026-09-18
2026-09-17S, sale reported on Form 49,978$2.5M2026-09-18
2026-09-17S, sale reported on Form 4638$160.6K2026-09-18

Pfizer INC (PFE)

Director · 27 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1224154) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms